TABLETS 10*15 by URSOZITA-300

URSOZITA-300

INR 553
Learn more
In stock

Description

URSOZITA-300

Ursodeoxycholic Acid Tablets 300 mg

Marketed By: Medroots Biopharma Pvt. Ltd.

A Trusted PCD Pharma Company

URSOZITA-300 contains Ursodeoxycholic Acid 300 mg, a medicine commonly prescribed to support liver and gallbladder health. It is widely used under medical supervision for managing certain liver disorders and dissolving cholesterol-rich gallstones.

Composition

Each film-coated tablet contains:

Ursodeoxycholic Acid IP – 300 mg

Uses of URSOZITA-300

URSOZITA-300 may be prescribed by healthcare professionals for:

Management of certain chronic liver conditions

Supportive care in cholestatic liver diseases

Dissolving cholesterol gallstones in selected patients

Improving bile flow and liver function

Hepatobiliary health management

Benefits

Helps improve bile circulation

Supports healthy liver function

Assists in reducing bile cholesterol saturation

Helps protect liver cells from bile acid damage

Well-formulated for effective therapeutic support

Dosage

Use strictly as directed by a registered medical practitioner.

Dosage may vary depending on the patient’s condition and medical advice.

Storage Instructions

Store in a cool, dry place

Protect from direct sunlight and moisture

Keep out of reach of children

Precautions

Use only under medical supervision

Inform your doctor about any existing liver, gallbladder, or pancreatic conditions

Not recommended for self-medication

Pregnant or breastfeeding women should consult a healthcare professional before use

Why Choose URSOZITA-300?

Quality-assured formulation

Manufactured with pharmaceutical standards

Trusted product from Medroots Biopharma Pvt. Ltd.

Ideal for pharma distribution and PCD franchise opportunities

About Medroots Biopharma Pvt. Ltd.

Medroots Biopharma Pvt. Ltd. is a reputed PCD Pharma Company dedicated to providing quality pharmaceutical and healthcare products across India. The company focuses on innovation, quality, affordability, and strong business partnerships.